Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Conditions:   Astrocytoma;   Brain Cancer;   Brain Metastases;   Bladder Cancer;   Breast Cancer;   Cervical Cancer;   Cholangiocarcinoma;   Colorectal Cancer;   Esophagus Cancer;   Gastric Cancer;   Head and Neck Cancer;   Kidney Cancer;   Liver Cancer;   Lung Cancer;   Melanoma;   Ovarian Cancer;   Pancreatic Cancer;   Pleural Mesothelioma;   Prostate Cancer;   Sarcoma;   Tongue Cancer;   Thymic Carcinoma;   Urinary Tract Cancer Intervention:   Drug: QBS10072S Sponsors:   Quadriga Biosciences, Inc.;   Novotech (Australia) Pty Limited Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials